Eva-Maria Ratai

Eva-Maria Ratai

Auto-generated profile, based on publicly available information

Eva-Maria Ratai

Department of Radiology, Harvard Medical School; Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Radiology
Verified
Journal Article
Closed access
GOGulin Oz
Gulin Oz
JAJeffry R. Alger
Jeffry R. Alger
PBPeter B. Barker
Peter B. Barker
RBRobert Bartha
Robert Bartha
ABAlberto Bizzi
Alberto Bizzi
FGFor the MRS Consensus Group
For the MRS Consensus Group
MR spectroscopy is used worldwide as an adjunct to MR imaging in several common neurologic diseases, including brain neoplasms, inherited metabolic disorders, demyelinating disorders, and infective... A large body of published work shows that proton (hydrogen 1 [1H]) magnetic resonance (MR) spectroscopy has evolved from a research tool into a clinical neuroimaging modality. Herein, the authors p...

1 September 2005 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KWKenneth Williams
Kenneth Williams
SWSusan Westmoreland
Susan Westmoreland
JGJane Greco
Jane Greco
EREva Ratai
Eva Ratai
MLMargaret Lentz
Margaret Lentz
RGR. Gilberto González
R. Gilberto González
Difficulties in understanding the mechanisms of HIV neuropathogenesis include the inability to study dynamic processes of infection, cumulative effects of the virus, and contributing host immune responses. We used 1H magnetic resonance spectroscopy and studied monocyte activation and progression of CNS neuronal injury in a CD8 lymphocyte depletion model of neuroAIDS in SIV-infected rhesus macaque monkeys. We found early, consistent neuronal injury coincident with viremia and SIV infection/activation of monocyte subsets and sought to define the role of plasma virus and monocytes in contributing to CNS disease. Antiretroviral therapy with essentially non–CNS-penetrating agents resulted in slightly decreased levels of plasma virus, a significant reduction in the number of activated and infected monocytes, and rapid, near-complete reversal of neuronal injury. Robust macrophage accumulation and productive virus replication were found in brains of infected and CD8 lymphocyte–depleted animals, but no detectable virus and few scattered infiltrating macrophages were observed in CD8 lymphocyte–depleted animals compared with animals not receiving antiretroviruses that were sacrificed at the same time after infection. These results underscore the role of activated monocytes and monocyte infection outside of the brain in driving CNS disease.

1 October 2007 in Stroke
Verified
Journal Article
Closed access
ASAneesh B. Singhal
Aneesh B. Singhal
EREva Ratai
Eva Ratai
TBThomas Benner
Thomas Benner
MVMark Vangel
Mark Vangel
VLVallent Lee
Vallent Lee
RGR. Gilberto Gonzalez
R. Gilberto Gonzalez
Background and Purpose— Recent studies suggest that normobaric oxygen therapy (NBO) is neuroprotective in acute ischemic stroke. Methods— We performed multivoxel magnetic resonance spectroscopic imaging and diffusion/perfusion MRI in patients with stroke treated with NBO or room air. Imaging was performed before, during, and after therapy. Results— Voxel-based analysis showed excellent correlation between apparent diffusion coefficient values, lactate, and N -acetyl-aspartate levels at all time points. Lactate decreased during NBO and increased post-NBO. N -acetyl-aspartate decreased in patients receiving room air but not in NBO-treated patients. Conclusion— These data suggest that NBO improves aerobic metabolism and preserves neuronal integrity in the ischemic brain.

1 April 2010 in Journal of Magnetic Resonance
Verified
Journal Article
Closed access
OAOvidiu Andronesi
Ovidiu Andronesi
SRSaadallah Ramadan
Saadallah Ramadan
EREva-Maria Ratai
Eva-Maria Ratai
DJDominique Jennings
Dominique Jennings
CMCarolyn E. Mountford
Carolyn E. Mountford
ASA. Gregory Sorensen
A. Gregory Sorensen

6 April 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJennifer H. Campbell
Jennifer H. Campbell
TBTricia H. Burdo
Tricia H. Burdo
PAPatrick Autissier
Patrick Autissier
JBJeffrey P. Bombardier
Jeffrey P. Bombardier
SWSusan V. Westmoreland
Susan V. Westmoreland
KWKenneth C. Williams
Kenneth C. Williams
Minocycline is a tetracycline antibiotic that has been proposed as a potential conjunctive therapy for HIV-1 associated cognitive disorders. Precise mechanism(s) of minocycline's functions are not well defined. Fourteen rhesus macaques were SIV infected and neuronal metabolites measured by proton magnetic resonance spectroscopy (1H MRS). Seven received minocycline (4 mg/kg) daily starting at day 28 post-infection (pi). Monocyte expansion and activation were assessed by flow cytometry, cell traffic to lymph nodes, CD16 regulation, viral replication, and cytokine production were studied. Minocycline treatment decreased plasma virus and pro-inflammatory CD14+CD16+ and CD14loCD16+ monocytes, and reduced their expression of CD11b, CD163, CD64, CCR2 and HLA-DR. There was reduced recruitment of monocyte/macrophages and productively infected cells in axillary lymph nodes. There was an inverse correlation between brain NAA/Cr (neuronal injury) and circulating CD14+CD16+ and CD14loCD16+ monocytes. Minocycline treatment in vitro reduced SIV replication CD16 expression on activated CD14+CD16+ monocytes, and IL-6 production by monocytes following LPS stimulation. Neuroprotective effects of minocycline are due in part to reduction of activated monocytes, monocyte traffic. Mechanisms for these effects include CD16 regulation, reduced viral replication, and inhibited immune activation.

1 January 2018 in NeuroImage: Clinical
Verified
Journal Article
Open access
EREva-Maria Ratai
Eva-Maria Ratai
MAMohamad J. Alshikho
Mohamad J. Alshikho
NZNicole R. Zürcher
Nicole R. Zürcher
MLMarco L. Loggia
Marco L. Loggia
CCCatherine L. Cebulla
Catherine L. Cebulla
NANazem Atassi
Nazem Atassi
To determine the relationship between brain tissue metabolites measured by in vivo magnetic resonance spectroscopy (1H-MRS), and glial activation assessed with [11C]-PBR28 uptake in people with amyotrophic lateral sclerosis (ALS). Forty ALS participants were evaluated clinically using the revised ALS functional rating scale (ALSFRS-R) and upper motor neuron burden (UMNB). All participants underwent simultaneous brain [11C]-PBR28 PET and MR imaging including diffusion tensor imaging to acquire fractional anisotropy (FA). [11C]-PBR28 uptake was measured as standardized uptake values normalized by whole brain mean (SUVR). 1H-MRS metabolite ratios (myo-inositol/creatine, mI/Cr; N-acetylaspartate/creatine, NAA/Cr) were measured within the precentral gyri and brain stem (regions known to be involved in ALS pathophysiology), and precuneus (which served as a control region). Whole brain voxel-wise correlation analyses were employed to identify brain regions exhibiting an association between metabolites within the VOIs and [11C]-PBR28 uptake. In the precentral gyri, [11C]-PBR28 uptake correlated positively with mI/Cr and negatively with NAA/Cr. The same correlations were not statistically significant in the brain stem, or in the control precuneus region. Whole brain voxel-wise correlation analyses between the estimated brain metabolites within the VOIs and SUVR were highly correlated in the precentral gyri. Decreased FA values in the precentral gyri were correlated with reduced NAA/Cr and elevated mI/Cr. Higher UMNB was correlated with increased [11C]-PBR28 uptake and mI/Cr, and decreased NAA/Cr. ALSFRS-R total score correlated positively with NAA/Cr and negatively with mI/Cr. Integrated PET-MR and 1H-MRS imaging demonstrates associations between markers for neuronal integrity and neuroinflammation and may provide valuable insights into disease mechanisms in ALS.